Actively Recruiting
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
Led by Lancaster General Hospital · Updated on 2025-01-30
150
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
Sponsors
L
Lancaster General Hospital
Lead Sponsor
M
Mayo Clinic
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective, single-arm clinical trial in which participants with dilated cardiomyopathy will invite their first degree relatives to undergo mobile cardiac, electrocardiogram screening.
CONDITIONS
Official Title
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female age 63 18 years
- Confirmed diagnosis of non-ischemic DCM with LVEF 64 45% at any time
- At least one living adult first-degree relative
- Able to provide informed consent
- First-degree relatives age 63 18 years
- Proband has provided informed consent
- First-degree relatives able to provide informed verbal consent
- Access to a smartphone or digital tablet with cellular data or Wi-Fi
You will not qualify if you...
- DCM due to secondary cardiomyopathy causes
- Proband previously informed relatives to get cardiac screening
- Ischemic cause of reduced LVEF or related heart events
- Moderate or greater primary valvular abnormality not due to cardiomyopathy
- Congenital structural heart disease
- Severe untreated or untreatable hypertension
- Cardiomyopathy from acute or reversible conditions (e.g., thyroid disorders, iron overload)
- Secondary causes of reduced LVEF such as pregnancy, myocarditis, amyloidosis, sarcoidosis, toxin exposure
- (CPC participants only) Home address outside travel range
- First-degree relatives previously informed or completed cardiac screening
- First-degree relatives previously diagnosed with reduced LVEF
- (CPC participants only) Home address outside travel range
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lancaster General Hospital
Lancaster, Pennsylvania, United States, 17602
Actively Recruiting
Research Team
H
Halle Becker, MPH
CONTACT
J
Jonathan Derr, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here